Industry / Germany
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
Record Financial Results For Bayer
February 2008 | Industry NewsSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
In the face of a challenging global operating environment, German-based drugmaker Bayer has announced record results, with its healthcare division driving much of the performance. Healthcare now accounts for 50% of revenues, up form 34% in 2005, with the difference being made by chemicals and crop science.